omalizumab
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, SUBCUTANEOUS | 150 mg | Restricted to outpatient use only. | ||||||||||
| SOLUTION, SUBCUTANEOUS | 75 mg/0.5 mL; 150 mg/mL | Restricted to outpatient use only. |